Mark Crotty Email & Phone Number
@junopharm.com.au
3 phones found area 142 and 212
LinkedIn matched
Who is Mark Crotty? Overview
A concise factual answer block for searchers comparing this professional profile.
Mark Crotty is listed as Interim Chief Executive Officer at LumaCina - Bridgewest Perth Pharma, a company with 10 employees, based in Gordon, New South Wales, Australia. AeroLeads shows a work email signal at junopharm.com.au, phone signal with area code 142, 212, and a matched LinkedIn profile for Mark Crotty.
Mark Crotty previously worked as Director at Crotty Laxon Pty Ltd and CEO and Managing Director at Juno Pharmaceuticals Pty Ltd. Mark Crotty holds Bachelor'S Degree, Business, Management, Marketing, And Related Support Services, Passed! from University Of Waikato.
Email format at LumaCina - Bridgewest Perth Pharma
This section adds company-level context without repeating Mark Crotty's masked contact details.
AeroLeads found 1 current-domain work email signal for Mark Crotty. Compare company email patterns before reaching out.
About Mark Crotty
A senior leader passionate about innovation and transformation/change management. Extensive experience with multi-national companies across Europe, Australia and New Zealand. Experience across a diverse range of industry sectors including healthcare (Medical Devices ; Wound care ;Retail and Hospital Generic medicines; Brand Pharmaceutical's, Over the counter pharmacy medicines ), beverages and FMCG packaged goods.Career achievements include:- leading a start up business, under the JUNO banner, in the Hospital generics sector resulting in a successful sale in 2023- leading the performance turnaround in Hospira ANZ (2013/15) to no 1 hospital generics position - Chairperson for the Australia Generics medicines association (GMiA) from July 2013 resulting in 5 year agreement with the Australia government- refocusing the South Europe (Ireland, Portugal, Greece, Belgium, Switzerland and Austria) Pfizer generics business through the European financial crisis (2011/12)- launch of a Greenfields business unit (Pfizer Established Products) and executed major innovations including a direct to pharmacy distribution model (2010); business development (60+ generic molecules) and pharmacy channel partnerships (Actavis)- the introduction of new marketing initiative's at Pfizer Australia involving the pitching of the $20 million account and revitalizing major brand campaigns (2008)- Creation and leadership of a industry lobby group for the US pharma companies in New Zealand (2006)- achievement of upper quartile ranking in employment satisfaction surveys (as measured by Gallup) in ANZ (2010)and Europe (2012)- launch of numerous new marketing initatives such as the launch of DB Bitter; the first every TV advertisment for beer in NZ and an advertising Axis award for Viagra
Listed skills include Strategy, Fmcg, Strategic Planning, Marketing Management, and 26 others.
Mark Crotty's current company
Company context helps verify the profile and gives searchers a useful next step.
Mark Crotty work experience
A career timeline built from the work history available for this profile.
Director
CurrentServices cover shorter term contract roles in Management Leadership roles; advising on strategy and change management and Board roles
Ceo And Managing Director
Juno Pharmaceuticals Australia/NZ was acquired by Arrotex Pharmaceuticals in July 2023 (a division of the DBG Group; a privately owned healthcare company with a presence in Australia and New Zealand) I held a minority shareholding in the business.From its inception in 2013, Juno grew to be the leading supplier of generic and biosimilar injectable medicines.
Managing Director Australia/Nz
Leading the ANZ organisation. Role formed due to the merging of all the S&N business units into one organisation based out of Sydney. Annual revenue approx UD $320mm and 350 employees.Market leader in medical devices and specialist wound care portfolios
Vice President Australia & New Zealand
Country Manager for the Hospira business. The business works across three main sectors - medical devices; hospital generics and specialist brands. The business is a market leader in the hospital generics area.
Chairman
Chairperson role of the industry sector for the generics and biosimilars trade industry association (previously known as the GMiA). This role was served concurrently with my responsibilities as VP ANZ Hospira. The GBMA represented the interests of members who provided over 90% of generic and biosimilar medicines in the Australian marketThe major.
Director
Management consulting services in Australia and New Zealand. The key areas of focus are strategic projects; developing of business plans and sales and marketing.
Vice President Pfizer South Cluster Europe Establsihed Products Bu
I led an organisation of six countries (Austria, Belgium, Greece, Ireland, Portugal and Switzerland) in the off patent medicines sector. Annual Revenues USD$625 million. 175 employees. Primary capabilities inspire country managers; refocus business through economic crisis reforms; innovate and P&L responsibility
General Manager - Australia/New Zealand
General manager for a greenfields business for Pfizer. Launched and developed the off patent (Established Products) business. The organisation grew through organic and M&A from approx $170MM to $340MM in 3 years. The major focus was preparing Pfizer for the patent expiry of $1 billion of brands (Lipitor $620MM); defending the current in line business and.
Brand Marketing Director
Brand caretaker for a $1 billion portfolio comprising a spend of $50MM and a team off 55 marketers and competitve intellience and market researchersPart of Australia Senior Leadership team and on local Pfizer Board
General Manager Pfizer New Zealand
General Manager for Pfizer New Zealand and for the Pharmaceuticals Group.This role involved providing leadership for the overall organisation and P&L responsibility for the Pharma group.Major focus were:- Direct to Consumer advertising for brands such as Viagra and Lipitor- Negotiation with the government on the funding of medicines- Leadership on external.
Business Unit Manager - Nz
Leader for the NZ business. This involved the management of mutiple businesses - Pharma, Pharmacy OTC and FMCGThe areas of focus were:- the launch of the largest global medicine Lipitor- the switch from Pharmacy only to open sellers (grocery) for a range of medicines- the leadership of the joint venture between Parke Davis and Wellcome (1993-95)
Sales And Marketing Manager
Managed the Pharmacy only brands for the Wellcome NZ organisation. Full P&L responsibility with a sales and marketing team
Brand Marketing Manager
Marketing leader for a range of beer brands. The most significant were the launch of a new brand, DB Bitter and revitalisation of Double Brown. I was also heavily involved in new television and sponsorships around teams such as NZ Cricket and the then Auckland Warriors
Group Product Manager - Dogfood Brands
Managing the dogfood portfolio at a time Uncle Bens (Mars Corportation) entered the market. major tasks involved building the brands via brand extensions; sponsorships and consumer advertising
Product Manager - Steinlager; Lion Red; Waikato
Responsible for management of the annual brand plan and execution of strategies for major Lion brands. The brand portfolio was Steinlager, Waikato and Lion Red involving supporting sponsorships around - "Drinking our Beer Here" Americas Cup, the All Blacks and Kiwis.
Brand Manager
Managing a range of smallgoods brands
Mark Crotty education
Bachelor'S Degree, Business, Management, Marketing, And Related Support Services, Passed!
Post Graduate Diploma, Business Administration And Management, General
Bachelor Of Management Studies, Business, Management, Marketing, And Related Support Services
Frequently asked questions about Mark Crotty
Quick answers generated from the profile data available on this page.
What company does Mark Crotty work for?
Mark Crotty works for LumaCina - Bridgewest Perth Pharma.
What is Mark Crotty's role at LumaCina - Bridgewest Perth Pharma?
Mark Crotty is listed as Interim Chief Executive Officer at LumaCina - Bridgewest Perth Pharma.
What is Mark Crotty's email address?
AeroLeads has found 1 work email signal at @junopharm.com.au for Mark Crotty at LumaCina - Bridgewest Perth Pharma.
What is Mark Crotty's phone number?
AeroLeads has found 3 phone signal(s) with area code 142, 212 for Mark Crotty at LumaCina - Bridgewest Perth Pharma.
Where is Mark Crotty based?
Mark Crotty is based in Gordon, New South Wales, Australia while working with LumaCina - Bridgewest Perth Pharma.
What companies has Mark Crotty worked for?
Mark Crotty has worked for Lumacina - Bridgewest Perth Pharma, Crotty Laxon Pty Ltd, Juno Pharmaceuticals Pty Ltd, Smith & Nephew, and Hospira.
How can I contact Mark Crotty?
You can use AeroLeads to view verified contact signals for Mark Crotty at LumaCina - Bridgewest Perth Pharma, including work email, phone, and LinkedIn data when available.
What schools did Mark Crotty attend?
Mark Crotty holds Bachelor'S Degree, Business, Management, Marketing, And Related Support Services, Passed! from University Of Waikato.
What skills is Mark Crotty known for?
Mark Crotty is listed with skills including Strategy, Fmcg, Strategic Planning, Marketing Management, Pharmaceutical Industry, Business Development, Sales Effectiveness, and P&L Management.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialCheck these profiles if this is not the Mark Crotty you were looking for.
View similar profiles